AIM
OSIR

Alambic Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Alambic Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,400
Closed -$59K – 637
2016
Q1 		$59K Buy
+10,400
New +$72.6K 0.02% 464

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Alambic Investment Management's OSIR Position: Q2 2016 in Review

Alambic Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2016, closing a stake of 10,400 shares — an estimated $59K sold.

Alambic Investment Management first reported a position in OSIR in Q1 2016 and held it in 1 quarter. The position peaked at $59K in Q1 2016. 68 funds tracked by Wall St. Rank hold OSIR as of Q2 2016.

  • Alambic Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Alambic Investment Management sold 10,400 Osiris Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $59K.
  • Alambic Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Alambic Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $59K in Q1 2016.
  • 68 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Alambic Investment Management's 13F filing for Q2 2016, filed 8 Aug 2016.